You are here: Industry Insights > J&J

News List

FDA authorises J&J Covid-19 vaccine substance made at Emergent’s plant pharmaceutical-technology
June 15, 2021
The US Food and Drug Administration (FDA) has approved, under the emergency use authorization (EUA), two batches of Johnson & Johnson (J&J) subsidiary Janssen’s Covid-19 vaccine drug substance produced at the Emergent BioSolutions’ plant in Baltimore, US.
With doses at risk of expiration in some states, J&J says it's working to extend the shelf-life of its Covid-19 vaccine firstwordpharma
June 10, 2021
As some US states warn they have Johnson & Johnson COVID-19 vaccine doses that are expiring before they get used, the company and federal officials are looking at whether expiration dates can be extended, reported CNN.
Expiration Date Looming for Millions of J&J COVID-19 Vaccine Doses drugs
June 10, 2021
U.S. federal and state health officials are trying to administer as many doses as possible of the Johnson & Johnson COVID-19 vaccine as millions of unused shots are set to expire this month.
J&J’s Tremfya shows significant improvements for post-TNFi psoriatic arthritis patients pharmatimes
June 04, 2021
Johnson & Johnson’s (J&J) interleukin-23 (IL-23) Tremfya has demonstrated positive results in post-tumour necrosis factor (TNF) inhibitor-treated psoriatic arthritis (PsA) patients.
UK approves J&J’s one-dose COVID-19 vaccine pharmatimes
June 01, 2021
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine.
Bio/pharma industry strives to solve shortage of viral vector used in many COVID-19 vaccines: GlobalData expresspharma
May 25, 2021
Viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the requirement for complex specialist facilities.
South Africa restarts inoculation with J&J’s Covid-19 vaccine pharmaceutical-technology
April 30, 2021
South Africa has resumed inoculation of health care workers with Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine after a pause of over two weeks due to rare blood clot reports.
US senators write to Pfizer, Moderna, J&J for global access to vaccines expresspharma
April 30, 2021
According to the letter, there are several steps that vaccine companies could take to expand access to the vaccines globally, including in India.
J&J COVID-19 vaccine may be imported by July expresspharma
April 25, 2021
India has said it would fast-track emergency approvals for COVID-19 vaccines authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson and Moderna shots.
US allows J&J COVID-19 vaccine shots to resume expresspharma
April 25, 2021
The United States can immediately resume the use of Johnson & Johnson’s COVID-19 vaccine, top health regulators said, ending a 10-day pause to investigate its link to extremely rare but potentially deadly blood clots.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page